Correspondence 0001493152-22-036858 from Indaptus Therapeutics, Inc. (INDP)
Indaptus Therapeutics, Inc.
Date: Dec. 30, 2022 · CIK: 0001857044 · Accession: 0001493152-22-036858
AI Filing Summary & Sentiment
File numbers found in text: 333-269000
Show Raw Text
CORRESP
1
filename1.htm
Indaptus
Therapeutics, Inc.
3
Columbus Circle
15th
Floor
New
York, New York 10019
December
30, 2022
Securities
and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Indaptus
Therapeutics, Inc.
Registration
Statement on Form S-1
File No. 333-269000
VIA
EDGAR
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Indaptus Therapeutics, Inc. (the “Registrant”) hereby respectfully
requests that the effectiveness of the Registration Statement on Form S-1 (File No. 333-269000) of the Registrant (the “Registration
Statement”) be accelerated so that the Company’s Registration Statement will be declared effective at 4.30 p.m., Eastern
Time, on December 30, 2022, or as soon thereafter as may be practicable.
The
undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel,
Greenberg Traurig, P.A., by calling Eyal Peled at (212) 801 9210. The Company hereby authorizes Mr. Peled to orally modify or withdraw
this request for acceleration.
Very
truly yours,
INDAPTUS
THERAPEUTICS, INC.
By:
/s/
Nir Sassi
Name:
Nir
Sassi
Title:
Chief
Financial Officer
cc:
Gary
Emmanuel (Greenberg Traurig, P.A.)